• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对 H1N1 流感病毒神经氨酸酶的新型天然多环化合物的计算研究。

Computational study on new natural polycyclic compounds of H1N1 influenza virus neuraminidase.

机构信息

Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, Jilin University, 2699 Qianjin Street, Changchun, 130012, China.

出版信息

J Mol Model. 2012 Aug;18(8):3445-53. doi: 10.1007/s00894-011-1349-0. Epub 2012 Jan 27.

DOI:10.1007/s00894-011-1349-0
PMID:22278046
Abstract

A new strain of influenza A (H1N1) virus is a major cause of morbidity and mortality around the world. The neuraminidase of the influenza virus has been the most potential target for the anti-influenza drugs such as oseltamivir and zanamivir. However, the emergence of drug-resistant variants of these drugs makes a pressing need for the development of new neuraminidase inhibitors for controlling illness and transmission. Here a 3D structure model of H1N1 avian influenza virus neuraminidase type 1 (N1) was constructed based on the structure of the template H5N1 avian influenza virus N1. Upon application of virtual screening technique for N1 inhibitors, two novel compounds (ZINC database ID: ZINC02128091, ZINC02098378) were found as the most favorable interaction energy with N1. Docking results showed that the compounds bound not only in the active pocket, but also in a new hydrophobic cave which contains Arg368, Trp399, Ile427, Pro431 and Lys432 of N1. Our result suggested that both of the screened compounds containing the hydrophobic group bring a strong conjugation effect with Arg293, Arg368 Lys432 of N1 by pi-pi interaction. However, the control inhibitors zanamivir and oseltamivir do not have this effect. The details of N1-compound binding structure obtained will be valuable for the development of a new anti-influenza virus agent.

摘要

一种新型甲型流感病毒(H1N1)是全球发病率和死亡率的主要原因。流感病毒的神经氨酸酶一直是奥司他韦和扎那米韦等抗流感药物最有潜力的靶点。然而,这些药物的耐药变异株的出现迫切需要开发新的神经氨酸酶抑制剂来控制疾病和传播。本研究基于 H5N1 禽流感病毒 N1 的结构模板,构建了 H1N1 禽流感病毒 N1 的三维结构模型。应用 N1 抑制剂的虚拟筛选技术,发现了两种新型化合物(ZINC 数据库 ID:ZINC02128091、ZINC02098378)与 N1 具有最有利的相互作用能。对接结果表明,这些化合物不仅结合在活性口袋中,还结合在一个新的疏水性洞穴中,该洞穴包含 N1 的 Arg368、Trp399、Ile427、Pro431 和 Lys432。研究结果表明,两种筛选出的含有疏水基团的化合物通过π-π 相互作用与 N1 的 Arg293、Arg368 和 Lys432 形成强烈的共轭效应。然而,对照抑制剂扎那米韦和奥司他韦没有这种作用。获得的 N1-化合物结合结构的细节将对开发新型抗流感病毒药物具有重要价值。

相似文献

1
Computational study on new natural polycyclic compounds of H1N1 influenza virus neuraminidase.针对 H1N1 流感病毒神经氨酸酶的新型天然多环化合物的计算研究。
J Mol Model. 2012 Aug;18(8):3445-53. doi: 10.1007/s00894-011-1349-0. Epub 2012 Jan 27.
2
Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1.长效神经氨酸酶抑制剂拉尼米韦对 H5N1 亚型和大流行 H1N1 流感病毒的结合模式。
J Mol Graph Model. 2012 Sep;38:148-54. doi: 10.1016/j.jmgm.2012.06.007. Epub 2012 Jul 4.
3
Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.探究奥司他韦(达菲)与2009年甲型H1N1流感病毒神经氨酸酶相互作用的见解。
Biochem Biophys Res Commun. 2009 Aug 28;386(3):432-6. doi: 10.1016/j.bbrc.2009.06.016. Epub 2009 Jun 10.
4
Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses.利用多维计算分析理解奥司他韦对甲型H1N1和H5N1流感神经氨酸酶突变的交叉耐药性。
Drug Des Devel Ther. 2015 Jul 31;9:4137-54. doi: 10.2147/DDDT.S81934. eCollection 2015.
5
Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1.对神经氨酸酶N1亚型催化口袋中已知药物-靶点相互作用的理解。
Proteins. 2008 Jun;71(4):1908-18. doi: 10.1002/prot.21897.
6
Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype.N1 神经氨酸酶亚型禽源和猪源流感病毒的抗病毒敏感性。
J Virol. 2010 Oct;84(19):9800-9. doi: 10.1128/JVI.00296-10. Epub 2010 Jul 21.
7
Theoretical studies on the susceptibility of oseltamivir against variants of 2009 A/H1N1 influenza neuraminidase.奥司他韦对 2009 年 A/H1N1 流感神经氨酸酶变异体敏感性的理论研究。
J Chem Inf Model. 2012 Oct 22;52(10):2715-29. doi: 10.1021/ci300375k. Epub 2012 Oct 2.
8
Impact of calcium on N1 influenza neuraminidase dynamics and binding free energy.钙对 N1 型流感神经氨酸酶动力学和结合自由能的影响。
Proteins. 2010 Aug 15;78(11):2523-32. doi: 10.1002/prot.22761.
9
Molecular basis of drug resistance in A/H1N1 virus.A/H1N1 病毒耐药性的分子基础。
J Chem Inf Model. 2012 Oct 22;52(10):2650-6. doi: 10.1021/ci300343w. Epub 2012 Oct 4.
10
In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase.基于计算机预测 2009 年甲型 H1N1 流感病毒神经氨酸酶的潜在耐药位点
Mol Pharm. 2010 Jun 7;7(3):894-904. doi: 10.1021/mp100041b.

本文引用的文献

1
Efficacy of neuraminidase (NA) inhibitors against H1N1 strains of different geographical regions: an in silico approach.神经氨酸酶(NA)抑制剂对不同地理区域 H1N1 株的疗效:一种计算机模拟方法。
Indian J Microbiol. 2009 Dec;49(4):370-6. doi: 10.1007/s12088-009-0065-2. Epub 2010 Jan 7.
2
A call for using natural compounds in the development of new antimalarial treatments - an introduction.呼吁在新抗疟药物开发中使用天然化合物 - 引言。
Malar J. 2011 Mar 15;10 Suppl 1(Suppl 1):S1. doi: 10.1186/1475-2875-10-S1-S1.
3
In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase.
基于计算机预测 2009 年甲型 H1N1 流感病毒神经氨酸酶的潜在耐药位点
Mol Pharm. 2010 Jun 7;7(3):894-904. doi: 10.1021/mp100041b.
4
QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors.黄酮类和双黄酮类作为流感 H1N1 病毒神经氨酸酶抑制剂的定量构效关系研究。
Eur J Med Chem. 2010 May;45(5):1724-30. doi: 10.1016/j.ejmech.2010.01.005. Epub 2010 Jan 14.
5
Homology modeling, docking, and molecular dynamics reveal HR1039 as a potent inhibitor of 2009 A(H1N1) influenza neuraminidase.同源建模、对接和分子动力学揭示 HR1039 是 2009 年 A(H1N1)流感神经氨酸酶的有效抑制剂。
Biophys Chem. 2010 Mar;147(1-2):74-80. doi: 10.1016/j.bpc.2009.12.002. Epub 2009 Dec 6.
6
Why are oseltamivir and zanamivir effective against the newly emerged influenza A virus (A/H1N1)?为什么奥司他韦和扎那米韦对新出现的甲型流感病毒(A/H1N1)有效?
Cell Res. 2009 Oct;19(10):1221-4. doi: 10.1038/cr.2009.111. Epub 2009 Sep 22.
7
AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.AutoDock Vina:通过新的评分函数、高效优化和多线程改进对接的速度和准确性。
J Comput Chem. 2010 Jan 30;31(2):455-61. doi: 10.1002/jcc.21334.
8
Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities.黄酮类化合物作为流感病毒神经氨酸酶抑制剂的构效关系及其体外抗病毒活性。
Bioorg Med Chem. 2008 Aug 1;16(15):7141-7. doi: 10.1016/j.bmc.2008.06.049. Epub 2008 Jun 28.
9
Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants.耐奥司他韦流感病毒神经氨酸酶突变体的晶体结构
Nature. 2008 Jun 26;453(7199):1258-61. doi: 10.1038/nature06956. Epub 2008 May 14.
10
Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.对神经氨酸酶抑制剂耐药的重组A/越南/1203/04(H5N1)流感病毒在体外和体内均保持其复制效率和致病性。
J Virol. 2007 Nov;81(22):12418-26. doi: 10.1128/JVI.01067-07. Epub 2007 Sep 12.